- Follow us
-
-
-
-
-
-
New Delhi, Dec 1: In what could determine the future of HIV treatment, scientists have found that a new generation cancer drug has shown remarkable results to boost the immune response of a patient.
According to reports, doctors in France have found the first evidence that a drug normally used to treat lung, kidney or skin cancer may be able to eradicate HIV-infected cells in people with the AIDS virus. (Also Read: World AIDS Day 2017: Myths Debunked About The HIV/AIDS)
A 51-year old patient was given nivolumab – sold as Opdivo by Bristol-Myers Squibb – saw a “drastic and persistent decrease” in the reservoirs of cells where HIV normally hides away and evades standard treatments.
Doctors are excited about the new discovery but have advised caution. They said more tests were needed to further establish the impact of the drug.
“We must remain careful, especially because this is only one case. This is the first case of such a drastic decrease of the HIV reservoir (but) we have…another case where there was no decrease,” Reuters quoted Jean-Philippe Spano, a professor and head of the medical oncology department at the Paris hospital, as saying.
For breaking news and live news updates, like us on Facebook or follow us on Twitter and Instagram. Read more on Latest World News on India.com.